APGE Operating Cash Flow (Statement)
Apogee Therapeutics Inc · Operating Cash Flow (Statement)
APGE Operating Cash Flow (Statement)
Latest reported-$71.38Mperiod ending
APGE Quarterly Cash from Operations ($0.00 → -$71.38M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
APGE operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -71,380,000 | |
| -55,570,000 | |
| -62,689,000 | |
| -54,255,000 | |
| -62,029,000 | |
| -48,477,000 | |
| -67,714,000 | |
| -42,524,000 | |
| -29,300,000 | |
| -31,636,000 | |
| -29,754,000 | |
| -19,880,000 | |
| -14,570,000 | |
| -10,557,000 | |
| -9,189,000 | |
| -7,238,000 | |
| 0 | |
| 0 |